Milan Analytica AG Switzerland
 

Clinical samples, diagnostic specimens, on request clinical data

Disease State


Hemostaseology

For inquiries please contact info@milananalytica.ch
  • Congenital alpha-2 antiplasmin deficiency plasma
  • Acquired alpha-2 antiplasmin deficiency plasma
  • Abnormal prothrombin time PT plasma
  • Abnormal activated partial prothrombin time aPTT plasma
  • Anti-beta2-glycoprotein-1 (b2GP1) antibody plasma
  • Anticardiolipin antibody plasma
  • Other antiphospholipid antibody positive plasmas
  • Anticoagulant plasma - direct thrombin inhibitors DTI - Argatroban (Argatra)
  • Anticoagulant plasma - direct thrombin inhibitors DTI - Lepirudin
  • Anticoagulant plasma - direct thrombin inhibitors DTI - Bivalirudin
  • Anti prothrombin antibody plasma
  • Congenital antithrombin deficiency plasma
  • Acquired antithrombin deficiency plasma
  • High antithrombin plasma
  • Activated protein C (APC) resistance heterozygous plasma
  • Activated protein C (APC) resistance homozygous plasma
  • D-Dimer set (30 x 1 ml)
  • D-Dimer positive plasma, up to 80,000 ng/ml FEU
  • D-Dimer plasma positive deep vein thrombosis/pulmonary embolism DVT/PE
  • D-Dimer plasma disseminated intravascular coagulation (DIC) diagnosis
  • Congenital factor II (prothrombin) deficiency plasma
  • Acquired factor II (prothrombin) deficiency plasma
  • Acquired high factor II (prothrombin) plasma
  • High factor II (prothrombin, G20210A mutation)
  • Congenital factor V deficiency plasma
  • Acquired factor V deficiency plasma
  • Acquired high factor V plasma
  • Congenital factor VII deficiency plasma
  • Acquired factor VII deficiency plasma
  • Acquired high factor VII plasma
  • Congenital factor VIII deficiency plasma
  • Acquired factor VIII deficiency plasma
  • Acquired factor VIII high plasma
  • Factor VIII inhibitor (antibodies) plasma (Bethesda)
  • Congenital factor IX deficiency plasma
  • Acquired factor IX deficiency plasma
  • Acquired high factor IX plasma
  • Factor IX inhibitors (antibodies) plasma (Bethesda)
  • Congenital factor X deficiency plasma
  • Acquired factor X deficiency plasma
  • Acquired high factor X plasma
  • Congenital factor XI deficiency plasma
  • Acquired factor XI deficiency plasma
  • Congenital factor XII deficiency plasma
  • Acquired factor XII deficiency plasma
  • Congenital factor XIII deficiency plasma
  • Fibrinogen plasma low and high, up to 2000 mg/dl
  • Fibrinogen linearity set 10 x 1 ml


  • Afibrinogenemia plasma
  • Hypofibrinogenemia plasma
  • Dysfibrinogenemia plasma
  • Hyperfibrinogenemia plasma
  • Hemolytic plasma
  • Heparin therapy (determined by aPTT) plasma
  • Heparin therapy (determined by anti-Xa level) plasma
  • Heparin-induced thrombocytopenia (HIT) positive serum
  • Low molecular weight heparin (LMWH) plasma - Dalteparin-sodium (Fragmin)
  • Low molecular weight heparin (LMWH) plasma - Enoxaparin-sodium (Lovenox)
  • Low molecular weight heparin (LMWH) plasma - Tinzaparin-sodium (Innohep)
  • Low molecular weight heparin (LMWH) plasma - Fondaparinux (Arixtra)
  • Bilirubin positive plasma (icteric plasma)
  • Congenital high molecular weight (HMW) kininogen deficiency plasma
  • Acquired high molecular weight (HMW) kininogen deficiency plasma
  • Lactate level heparin plasma
  • Lipemic plasma (hypertriglyceride plasma)
  • Liver disease patient plasma
  • Lupus anticoagulant plasma (defined by dRVVT or lupus-sensitive aPTT)
  • Normal donor plasma
  • Factor V leiden negative plasma (APC ratio, PCR)
  • Normal plasma - (specialty anticoagulant, EDTA, CDTA, Li heparin, 3.2%/3.8% citrate)
  • Oral antiocagulant plasma, defined by INR
  • Congenital plasminogen deficiency plasma
  • Acquired plasminogen deficiency plasma
  • Congenital prekallikrein (PK) deficiency plasma
  • Acquired prekallikrein (PK) deficiency plasma
  • Congenital protein C deficiency plasma
  • Acquired protein C deficiency plasma
  • Congenital protein S deficiency plasma
  • Acquired protein S deficiency plasma
  • Renal failure plasma
  • Control plasma - TAT (thrombin / antithrombin complex)
  • Control plasma - PF 1.2 (prothrombin fragment 1.2)
  • Control plasma - PAI-1 (plasminogen activator inhibitor)
  • Vitamin K deficiency plasma
  • Von Willebrand disease type 1 plasma
  • Von Willebrand disease type 2A plasma
  • Von Willebrand disease type 2B plasma
  • Von Willebrand disease type 2M plasma
  • Von Willebrand disease type 2N plasma
  • Von Willebrand disease type 3 plasma
  • Whole blood - normal hematocrit (HCT)
  • Whole blood - low hematocrit (HCT)
  • Whole blood - high hematocrit (HCT)
 

 

 

 

MILAN ANALYTICA AG Baslerstrasse 15 4310 Rheinfelden Switzerland phone 0041 61 845 99 88 fax 0041 61 845 99 87 info@milananalytica.ch